Press Releases
-
Definiens and MolecularMD Announce Partnership to Combine IHC Assays with Advanced Digital Pathology and Data Mining
MUNICH, UNITED STATES - Jun 7, 0016 - Definiens, the pioneer in Tissue Phenomics solutions for diagnostics development and commercialization, today announced a partnership agreement with MolecularMD to combine MolecularMDs expertise in specialty diagnostic assays with Definiens quantitative tissue read-outs
Jun 7, 2016
-
Rho-Supported Study Wins the David Sackett Trial of the Year Award from the Society for Clinical Trials
CHAPEL HILL, NC, UNITED STATES - Jun 7, 2016 - Rho, a full-service contract research organization (CRO) focused on bringing new products to market through a full range of product development services, was recently honored as part of the clinical trial team for the LEAP Trial: Randomized Trial of Peanut Consumption in Infants at Risk for Peanut Allergy
Jun 7, 2016
-
Former NCI and NIH Director Dr. Harold Varmus Joins The International Biomedical Research Alliance Board
BETHESDA, MD - Jun 2, 2016 - The International Biomedical Research Alliance, a non-profit organization which provides programming and funding support for the National Institutes of Health (NIH) Oxford-Cambridge Scholars Program, today announced that Harold Varmus, MD, is joining the Alliances board of directors
Jun 2, 2016
-
Rho Named Best CRO with Life Sciences Award from Triangle Business Journal
CHAPEL HILL, NC, UNITED STATES - May 31, 2016 - Rho, a full-service contract research organization (CRO) focused on bringing new products to market through a full range of product development services, recently announced that the company was named the 2016 Best CRO by Triangle Business Journal, a multimedia source for local business news, research and events in the Raleigh, Durham and Chapel Hill region of North Carolina, where Rho is headquartered
May 31, 2016
-
Certara and The University of Manchester Co-host Inaugural Model-based Personalized Drug Dosing in Healthcare Conference
PRINCETON, NJ - May 25, 2016 - Certara®, the global biosimulation technology-enabled drug development company, in partnership with The University of Manchester, successfully organized the first-ever Health Care Summit on Model-based Precision Dosing on May 19-20 in the UK
May 25, 2016
-
Rho Donates $28,000 to the March of Dimes
CHAPEL HILL, NC, UNITED STATES - May 24, 0016 - Rho Donates $28,000 to the March of DimesChapel Hill-based company hosts a variety of employee events to help raise funds for charity Chapel Hill, NC ̶ May 24, 2016 ̶ Rho, a Chapel Hill-based full-service contract research organization (CRO) focused on bringing new products to market through a complete range of product development services, announced today that it has donated $28,000 to the March of Dimes
May 24, 2016
-
ERT Integrates Circassia’s FeNO Device to Assess Patient Airway Inflammation
PHILADELPHIA, PA, UNITED STATES - May 17, 2016 - ERT, a leading provider of high-quality patient data collection solutions for use in clinical drug development, today announced it has successfully integrated the market-leading Fractional exhaled Nitric Oxide (FeNO) measurement device by Aerocrine—a Circassia subsidiary— into ERTs diagnostic platform for spirometry, ECG and home monitoring for centralized clinical trials
May 17, 2016
-
Dr. Adam Darwich is Appointed Certara Lecturer in Precision Dosing at The University of Manchester, England
PRINCETON, NJ - May 12, 2016 - Certara®, the global biosimulation technology-enabled drug development company, today announced that Adam Darwich, PhD, has been appointed Certara Lecturer in Precision Dosing at the Manchester Pharmacy School at The University of Manchester in England
May 12, 2016
-
Clintrax Global Named as Finalist for Triangle Business Journal’s 2016 Life Sciences Awards
PRINCETON, NJ - May 11, 2016 - WIRB-Copernicus Group® (WCG), one of the world's leading providers of solutions that measurably improve the quality and efficiency of clinical research, today announced that its Clintrax Global company has been named a finalist for the Triangle Business Journals (TBJs) 2016 Life Sciences Awards
May 11, 2016
-
Definiens’ Symposium Finds Tissue Context of Tumor is Key to Cancer Immunotherapy Success
MUNICH, GERMANY - May 10, 2016 - Definiens, the pioneer in Tissue Phenomics® solutions for diagnostics development, has announced findings from the International Symposium, a sold-out gathering of international researchers and clinicians on April 27-28 in Boston, Massachusetts to discuss advancements in oncology and the application of Tissue Phenomics
May 10, 2016
-
PharmaSeek Partners with PRCCI to Enhance Clinical Research in Puerto Rico
MIDDLETON, WI, UNITED STATES - May 4, 2016 - PharmaSeek LLC, an Investigative Site Network (ISN), is expanding the reach of its network by partnering with the Puerto Rico Consortium for Clinical Investigation (PRCCI)
May 4, 2016
-
Certara Launches New E-learning Platform for Biosimulation Education
PRINCETON, NJ - Apr 28, 2016 - Certara®, the global biosimulation technology-enabled drug development company, today launched an e-learning platform through Certara University to satisfy the increased need for education in the burgeoning field of biosimulation or model-based drug development
Apr 28, 2016
-
Oasmia Pharmaceutical Announces Positive Overall Survival Results from Phase III Study of Paclical/Apealea for Treatment of Ovarian Cancer
NEW YORK, NY, UNITED STATES - Apr 27, 2016 - April 27, 2016 -- Oasmia Pharmaceutical AB (OASM), a developer of a new generation of drugs within human and veterinary oncology, today announced positive overall survival results for Paclical/Apealea in the Phase III study that included a total of 789 patients with epithelial ovarian cancer
Apr 27, 2016
-
Montrium Releases eTMF Navigator to Provide Greater Business Intelligence in Clinical Trials
MONTREAL, QC, CANADA - Apr 28, 2016 - Montrium, clinical trial technology specialists, and electronic content management software providers, today, announced the commercial release of the eTMF Navigator, an interactive intelligence dashboard integrated into eTMF Connect
Apr 27, 2016
-
Queen’s University Belfast and Domainex Win Late-Stage Award to Progress Novel Lung Cancer Drug Candidate into the Clinic
BELFAST AND CAMBRIDGE, UK - Apr 26, 2016 - Queens University Belfast and Domainex Ltd. announced today that they have secured a late-stage award from the Wellcome Trust Seeding Drug Discovery scheme to advance therapeutic candidate molecules into clinical evaluation for treatment of non-small cell lung carcinoma (NSCLC)
Apr 26, 2016
-
Bracket Announces New Patient Engagement Tools for eCOA and RTSM Products
WAYNE, PA, UNITED STATES - Apr 20, 2016 - A Bracket, a leading clinical trial specialty services provider, announced platform updates to Bracket eCOATM and Bracket RTSMTM to include native support for SMS messaging with patients and other stakeholders in clinical research programs
Apr 21, 2016
-
Post-Authorization Study Develops Into Crucial Part of Drug Development Design
BERLIN, GERMANY - Apr 20, 2016 - Post-authorization safety studies (PASS) are becoming an integral part of the medicines development. Planning the design of PASS in the early phases of a clinical trial will translate into significant time- and cost-efficiency of pre-approval research
Apr 20, 2016
-
Rho to Highlight Clinical Trial Expertise, Recruit New Team Members During ACRP 2016 Global Conference
CHAPEL HILL, NC - Apr 12, 2016 - Rho, a full-service contract research organization (CRO), is hiring a number of clinical research positions and will be looking to meet potential applicants in the field at the Association of Clinical Research Professionals (ACRP) during the groups 2016 Global Conference, being held April 16-19 in Atlanta, Georgia
Apr 12, 2016
-
Certara Launches the SIVA Toolkit 2.0 to Improve Analysis of In Vitro Drug Development Data
PRINCETON, NJ - Apr 12, 2016 - Certara®, the global biosimulation technology-enabled drug development company, today launched the Simcyp In Vitro (Data) Analysis (SIVA) Toolkit 2
Apr 12, 2016
-
ANT Neuro announces cooperation with MAG & More in high-performance rTMS stimulators.
ENSCHEDE, N/A, THE NETHERLANDS - Apr 6, 2016 - ANT Neuro b.v., part of neuromotion b.v., is pleased to announce its cooperation with MAG & More GmbH in offering high performance, top of the range navigated TMS solutions for the advanced applications in research and clinical care
Apr 5, 2016
